Effects of exercise on nonalcoholic fatty liver disease

The effect of six weeks combined aerobic and resistance exercise training on some liver function parameters in Middle-aged men with non-alcoholic fatty liver disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017011821258N2

Enrollment

Registered

2017-02-19

Start date

2014-12-31

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease (NAFLD). Nonalcoholic fatty liver disease (NAFLD)

Interventions

Intervention 1: The intervention group participants performed six weeks and three sessions per week combined of aerobic and resistance training that Including: 60-90 minutes aerobic exercise With an i

Lifestyle

The control group participants continued with their usual activities, which may have included leisure and sporting activities but did not include a progressive resistance and aerobic training program.

The intervention group participants performed six weeks and three sessions per week combined of aerobic and resistance training that Including: 60-90 minutes aerobic exercise With an intensity of 45-7

Eligibility

Sex/Gender

Male

Age

30 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. non-alcoholic fatty liver disease; 2. males; 3. having the age range of 45-30 years old. Exclusion criteria: 1. under the age of 30 years ; 2. age over 45 years old; 3. patients with cardiovascular disease; 4. patients with high blood pressure; 5. patients who have studied interoperability; 6. patients with musculoskeletal disorders; 7. people with Medical ban to participate in sports activities; 8. alcohol consumption.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood Alanine Aminotransferase Enzyme (ALT). Timepoint: Baseline and final (6th week). Method of measurement: Blood samples test.;Blood Aspartate Aminotransferase Enzyme (AST). Timepoint: Baseline and final (6th week). Method of measurement: Blood samples test.;Liver fats. Timepoint: Baseline and final (6th week). Method of measurement: Liver ultrasound.;Body weight. Timepoint: Baseline and final (6th week). Method of measurement: Digital balance.;Body mass index. Timepoint: Baseline and final (6th week). Method of measurement: Weight (kg) divided by square of height (m).;Maximum oxygen uptake. Timepoint: Baseline and final (6th week). Method of measurement: Rockport Fitness Walking Test.;Waist-to-hip ratio (WHR). Timepoint: Baseline and final (6th week). Method of measurement: Waist circumference divided by hip circumference.;Body fat percent. Timepoint: baseline and final (6th week). Method of measurement: Measurement of skin fold thickness.	—

Measure

Time frame

Blood Alanine Aminotransferase Enzyme (ALT). Timepoint: Baseline and final (6th week). Method of measurement: Blood samples test.;Blood Aspartate Aminotransferase Enzyme (AST). Timepoint: Baseline and final (6th week). Method of measurement: Blood samples test.;Liver fats. Timepoint: Baseline and final (6th week). Method of measurement: Liver ultrasound.;Body weight. Timepoint: Baseline and final (6th week). Method of measurement: Digital balance.;Body mass index. Timepoint: Baseline and final (6th week). Method of measurement: Weight (kg) divided by square of height (m).;Maximum oxygen uptake. Timepoint: Baseline and final (6th week). Method of measurement: Rockport Fitness Walking Test.;Waist-to-hip ratio (WHR). Timepoint: Baseline and final (6th week). Method of measurement: Waist circumference divided by hip circumference.;Body fat percent. Timepoint: baseline and final (6th week). Method of measurement: Measurement of skin fold thickness.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Ali Samavati Sharif

Bu Ali Sina University of Hamadan

ali.samavati@gmail.com+98 81 3829 2614

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026